Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaushik Chanda

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Nanoscale|October 30, 2013
Investigation of facet effects on the catalytic activity of Cu2O nanocrystals for efficient regioselective synthesis of 3,5-disubstituted isoxazolesKaushik Chanda, Sourav Rej, Michael H Huang
Life Sciences|May 22, 2022
Long non-coding RNA MALAT1 protects against Aβ<sub>1-42</sub> induced toxicity by regulating the expression of receptor tyrosine kinase EPHA2 via quenching miR-200a/26a/26b in Alzheimer's diseaseKaushik Chanda, Nihar Ranjan Jana, Debashis Mukhopadhyay
Chemmedchem|November 14, 2018
Assembly of Fully Substituted 2H-Indazoles Catalyzed by Cu<sub>2</sub> O Rhombic Dodecahedra and Evaluation of Anticancer ActivityRajeeva Lochana Panchangam, Venkatraman Manickam, Kaushik Chanda
Scientific Reports|September 29, 2021
Receptor tyrosine kinase ROR1 ameliorates Aβ<sub>1-42</sub> induced cytoskeletal instability and is regulated by the miR146a-NEAT1 nexus in Alzheimer's diseaseKaushik Chanda, Nihar Ranjan Jana, Debashis Mukhopadhyay
Chemistry & Biodiversity|December 18, 2023
An in silico approach to investigate the theranostic potential of coumarin-derived self-immolative luminescent probesSwathi Venkatesan, Kaushik Chanda, M M Balamurali
Expert Opinion on Therapeutic Patents|November 17, 2018
Evaluation of WO2014121383 A1: a process for preparation of rufinamide and intermediatesBarnali Maiti, Balamurali M M, Kaushik Chanda
ACS Omega|September 13, 2021
Overview of Pathogenesis, Diagnostics, and Therapeutics of Infectious Diseases: Dengue and ZikaBrindha Jayachandran, Kaushik Chanda, Musuvathi Motilal Balamurali
ACS Omega|September 18, 2023
Recent Advancements of Aptamers in Cancer TherapySwathi Venkatesan, Kaushik Chanda, Musuvathi Motilal Balamurali
Organic & Biomolecular Chemistry|January 22, 2025
Ionic-liquid-supported copper-promoted synthesis of 3,5-disubstituted-1,2,4-triazolesSoumyadip Das, Badruzzaman Choudhury, Barnali Maiti, et al.
The Journal of Organic Chemistry|August 23, 2019
One-Pot, Telescopic Approach for the Chemoselective Synthesis of Substituted Benzo[<i>e</i>]pyrido/pyrazino/pyridazino[1,2-<i>b</i>][1,2,4]thiadiazine dioxides and Their Significance in Biological Systems †Ramsingh Dhanbahadur Padmaja, Musuvathi Motilal Balamurali, Kaushik Chanda
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Nanoscale|October 30, 2013
Investigation of facet effects on the catalytic activity of Cu2O nanocrystals for efficient regioselective synthesis of 3,5-disubstituted isoxazolesKaushik Chanda, Sourav Rej, Michael H Huang
Life Sciences|May 22, 2022
Long non-coding RNA MALAT1 protects against Aβ<sub>1-42</sub> induced toxicity by regulating the expression of receptor tyrosine kinase EPHA2 via quenching miR-200a/26a/26b in Alzheimer's diseaseKaushik Chanda, Nihar Ranjan Jana, Debashis Mukhopadhyay
Chemmedchem|November 14, 2018
Assembly of Fully Substituted 2H-Indazoles Catalyzed by Cu<sub>2</sub> O Rhombic Dodecahedra and Evaluation of Anticancer ActivityRajeeva Lochana Panchangam, Venkatraman Manickam, Kaushik Chanda
Scientific Reports|September 29, 2021
Receptor tyrosine kinase ROR1 ameliorates Aβ<sub>1-42</sub> induced cytoskeletal instability and is regulated by the miR146a-NEAT1 nexus in Alzheimer's diseaseKaushik Chanda, Nihar Ranjan Jana, Debashis Mukhopadhyay
Chemistry & Biodiversity|December 18, 2023
An in silico approach to investigate the theranostic potential of coumarin-derived self-immolative luminescent probesSwathi Venkatesan, Kaushik Chanda, M M Balamurali
Expert Opinion on Therapeutic Patents|November 17, 2018
Evaluation of WO2014121383 A1: a process for preparation of rufinamide and intermediatesBarnali Maiti, Balamurali M M, Kaushik Chanda
ACS Omega|September 13, 2021
Overview of Pathogenesis, Diagnostics, and Therapeutics of Infectious Diseases: Dengue and ZikaBrindha Jayachandran, Kaushik Chanda, Musuvathi Motilal Balamurali
ACS Omega|September 18, 2023
Recent Advancements of Aptamers in Cancer TherapySwathi Venkatesan, Kaushik Chanda, Musuvathi Motilal Balamurali
Organic & Biomolecular Chemistry|January 22, 2025
Ionic-liquid-supported copper-promoted synthesis of 3,5-disubstituted-1,2,4-triazolesSoumyadip Das, Badruzzaman Choudhury, Barnali Maiti, et al.
The Journal of Organic Chemistry|August 23, 2019
One-Pot, Telescopic Approach for the Chemoselective Synthesis of Substituted Benzo[<i>e</i>]pyrido/pyrazino/pyridazino[1,2-<i>b</i>][1,2,4]thiadiazine dioxides and Their Significance in Biological Systems †Ramsingh Dhanbahadur Padmaja, Musuvathi Motilal Balamurali, Kaushik Chanda
Pageof 7